AMENDMENT NO. 1 TO AT-THE-MARKET ISSUANCE SALES AGREEMENTCorMedix Inc. • December 8th, 2017 • Pharmaceutical preparations • New York
CorMedix Inc. (the “Company”) and MLV & Co. LLC (“MLV”) are parties to that certain At-the-Market Issuance Sales Agreement dated April 8, 2015 (the “Original Agreement”). All capitalized terms not defined herein shall have the meanings ascribed to them in the Original Agreement. The parties, together with B. Riley FBR, intending to be legally bound, hereby amend the Original Agreement as follows:
